摘要
目的对甲钴胺联合多潘立酮使用于糖尿病性胃轻瘫的疗效进行分析探讨。方法选择2013年11月—2014年11月时间段该院接收的100例糖尿病性胃轻瘫患者,分成为研究组与对照组,各50例,对照组仅采取多潘立酮治疗,研究组基于对照组采取甲钴胺联合治疗,就两个组别患者临床治疗效果展开对比研究。结果研究组用药后症状总评分(6.1±3.5)、胃半排空时间(124.7±22.5)min相较于对照组(10.2±5.1)、(193.3±26.8)min明显更低,数据差异有统计学意义(P<0.05);研究组总有效率94.0%相较于对照组74.0%明显更佳,数据差异有统计学意义(P<0.05)。结论甲钴胺联合多潘立酮使用于治疗糖尿病性胃轻瘫患者临床疗效理想,可明显改善患者体征症状,具备推广借鉴价值。
Objective Analyze the effect of Mecobalamin domperidone treatment of diabetic gastroparesis. Methods Select 100 cases of diabetic gastroparesis patients from November 2013 to November 2014 period in our hospital who were divided into the study group and the control group, 50 patients in each group;the control group was received only domperidone ther-apy, the study group was received mecobalamin treatment based on the clinical treatment,then compare their effects. Re-sults The study group’s total symptom score after treatment is （6.1 ± 3.5）, gastric half emptying time is（124.7 ± 22.5） min is significantly lower compared to the control group （10.2 ± 5.1）, （193.3 ± 26.8） min, the data were significantly different （P〈0.05）; the study group’s total efficiency of 94.0% compared to 74.0% in the control group was significantly better, the data were significantly different （P〈0.05）, Conclusion Mecobalamin domperidone used in the treatment of patients with clinical diabetic gastroparesis had ideal effect, which can significantly improve symptoms and signs, with the promotion of reference value.
出处
《糖尿病新世界》
2015年第16期19-20,共2页
Diabetes New World Magazine
关键词
甲钴胺
多潘立酮
糖尿病性胃轻瘫
临床疗效
Mecobalamin
Domperidone
Diabetic gastroparesis
Clinical efficacy
